Publications by authors named "Uwe Mellinger"

Claim this Profile
E
Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause: OASIS 1 and 2 Randomized Clinical Trials.
JoAnn V Pinkerton, James A Simon, Hadine Joffe, Pauline M Maki, Rossella E Nappi, Uwe Mellinger

JAMA· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of OASIS 1 and 2: phase 3 clinical trials assessing the efficacy and safety of elinzanetant for the treatment of vasomotor symptoms associated with menopause.
JoAnn V Pinkerton, James Simon, Nick Panay, Christian Seitz, Susanne Parke, Uwe Mellinger

Menopause· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absence of Drug-Drug Interaction of Anastrozole on Levonorgestrel Delivered Simultaneously by an Intravaginal Ring: Results of a Phase 2 Trial.
Rüdiger Nave, Uwe Mellinger, Stefan Klein, Joachim Höchel, Heinz Schmitz

J Clin Pharmacol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of a low-dose contraceptive patch on efficacy, bleeding pattern, and safety: a 1-year, multicenter, open-label, uncontrolled study.
Inka Wiegratz, Susana Bassol, Edith Weisberg, Uwe Mellinger, Martin Merz

Reprod Sci· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Different Pearl Indices in studies of hormonal contraceptives in the United States: impact of study population.
Christoph Gerlinger, James Trussell, Uwe Mellinger, Martin Merz, Joachim Marr

Contraception· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estradiol valerate plus dienogest versus ethinylestradiol plus levonorgestrel for the treatment of primary dysmenorrhea.
Felice Petraglia, Susanne Parke, Marco Serrani, Uwe Mellinger, Thomas Römer

Int J Gynaecol Obstet· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of a combined oral contraceptive containing estradiol valerate/dienogest: results from a clinical study conducted in North America.
Anita Nelson, Susanne Parke, Uwe Mellinger, Edio Zampaglione, Anja Schmidt

J Womens Health (Larchmt)· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Change to either a nonandrogenic or androgenic progestin-containing oral contraceptive preparation is associated with improved sexual function in women with oral contraceptive-associated sexual dysfunction.
Susan R Davis, Johannes Bitzer, Annamaria Giraldi, Santiago Palacios, Susanne Parke, Uwe Mellinger

J Sex Med· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hormone withdrawal-associated symptoms: comparison of oestradiol valerate/dienogest versus ethinylestradiol/norgestimate.
Jeffrey T Jensen, Susanne Parke, Uwe Mellinger, Marco Serrani, R Garn Mabey

Eur J Contracept Reprod Health Care· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and bleeding profile of a combined oral contraceptive containing oestradiol valerate/dienogest: a pooled analysis of three studies conducted in North America and Europe.
Anita Nelson, Susanne Parke, Dagmar Makalova, Marco Serrani, Santiago Palacios, Uwe Mellinger

Eur J Contracept Reprod Health Care· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the effects of rifampicin, ketoconazole and erythromycin on the steady-state pharmacokinetics of the components of a novel oral contraceptive containing estradiol valerate and dienogest in healthy postmenopausal women.
Hartmut Blode, Susan Zeun, Susanne Parke, Torsten Zimmermann, Beate Rohde, Uwe Mellinger

Contraception· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Normalization of blood loss in women with heavy menstrual bleeding treated with an oral contraceptive containing estradiol valerate/dienogest.
Ian S Fraser, Jeffrey Jensen, Matthias Schaefers, Uwe Mellinger, Susanne Parke

Contraception· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimation of menstrual blood loss volume based on menstrual diary and laboratory data.
Ulrike Schumacher, Jens Schumacher, Uwe Mellinger, Christoph Gerlinger, Andreas Wienke

BMC Womens Health· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemostatic effects of a novel estradiol-based oral contraceptive: an open-label, randomized, crossover study of estradiol valerate/dienogest versus ethinylestradiol/levonorgestrel.
Christine Klipping, Ingrid Duijkers, Susanne Parke, Uwe Mellinger, Marco Serrani

Drugs R D· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic and haemostatic effects of estradiol valerate/dienogest, a novel oral contraceptive: a randomized, open-label, single-centre study.
Wolfgang Junge, Uwe Mellinger, Susanne Parke, Marco Serrani

Clin Drug Investig· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of extended-cycle regimen with an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on bleeding patterns, safety, acceptance and contraceptive efficacy.
Inka Wiegratz, Skadi Stahlberg, Torsten Manthey, Nicole Sänger, Katrin Mittmann, Uwe Mellinger

Contraception· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective treatment of heavy and/or prolonged menstrual bleeding without organic cause: pooled analysis of two multinational, randomised, double-blind, placebo-controlled trials of oestradiol valerate and dienogest.
Ian S Fraser, Susanne Parke, Uwe Mellinger, Andrea Machlitt, Marco Serrani

Eur J Contracept Reprod Health Care· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: a randomized controlled trial.
Jeffrey T Jensen, Susanne Parke, Uwe Mellinger, Andrea Machlitt, Ian S Fraser

Obstet Gynecol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on lipid metabolism during 1 year of conventional or extended-cycle use.
Inka Wiegratz, Skadi Stahlberg, Torsten Manthey, Nicole Sänger, Katrin Mittmann, Uwe Mellinger

Contraception· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel.
Hans-Joachim Ahrendt, Dagmar Makalová, Susanne Parke, Uwe Mellinger, Diana Mansour

Contraception· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of conventional or extended-cycle regimen of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on various hemostasis parameters.
Inka Wiegratz, Skadi Stahlberg, Torsten Manthey, Nicole Sänger, Katrin Mittmann, Uwe Mellinger

Contraception· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on thyroid hormones and androgen parameters: conventional vs. extended-cycle use.
Nicole Sänger, Skadi Stahlberg, Torsten Manthey, Katrin Mittmann, Uwe Mellinger

Contraception· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1mg estradiol valerate/2mg dienogest on hot flushes in postmenopausal women.
Jan Endrikat, Thomas Graeser, Uwe Mellinger, Kubilay Ertan, Cornelia Holz

Maturitas· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis